1 Introduction
==============

Mathematical modeling of many biological systems requires solving for secretion, diffusion, uptake and decay of multiple substrates in three dimensions. Cells change phenotype (division rate, metabolism, secretions, etc.) in response to their microenvironment; the spatial distribution of cells (and their uptake and secretion of substrates) alters the substrates' distribution, affecting later cell behavior ([@btv730-B2]). BioFVM solves PDEs driven by such problems, of the form $$\frac{\partial\overrightarrow{\rho}}{\partial t} = \overset{\text{diffusion}}{\overset{︷}{\overrightarrow{D}\nabla^{2}\overrightarrow{\rho}}} - \overset{\text{decay}}{\overset{︷}{\overrightarrow{\lambda}\overrightarrow{\rho}}} + \overset{\text{bulk}\,\text{source}\,}{\overset{︷}{\overrightarrow{S}({\overrightarrow{\rho}}^{*}-\overrightarrow{\rho})}} - \overset{\text{bulk}\,\text{uptake}\,}{\overset{︷}{\overrightarrow{U}\overrightarrow{\rho}}}$$ $$+ \overset{\text{sources}\,\text{and}\,\text{uptake}\,\text{by}\,\text{cells}}{\overset{︷}{{\underset{\text{cells}k}{\sum}1_{k}}(\overrightarrow{x})\left\lbrack {{\overrightarrow{S}}_{k}({\overrightarrow{\rho}}_{k}^{*}-\overrightarrow{\rho})-{\overrightarrow{U}}_{k}\overrightarrow{\rho}} \right\rbrack}}\,\text{in}\,\Omega$$ with zero flux conditions on $\partial\Omega$. Here, Ω is the computational domain with boundary $\partial\Omega,\,\overrightarrow{\rho}$ is the vector of substrate densities, ${\overrightarrow{\rho}}^{*}$ are the substrate saturation densities, $\overrightarrow{D}$ are the diffusion coefficients, $\overrightarrow{\lambda}$ are the decay rates, $\overrightarrow{S}$ and $\overrightarrow{U}$ are the supply and uptake rates (may vary throughout the domain), $\left\{ {({\overrightarrow{x}}_{k},W_{k},{\overrightarrow{S}}_{k},{\overrightarrow{U}}_{k},{\overrightarrow{\rho}}_{k}^{*}):1 \leq k \leq N(t)} \right\}$ is a collection of cells centered at ${\overrightarrow{x}}_{k}$ with volume *W~k~*, supply and uptake rates ${\overrightarrow{S}}_{k}$ and ${\overrightarrow{U}}_{k}$ and saturation densities ${\overrightarrow{\rho}}_{k}^{*}$. $1_{k}(\overrightarrow{s})$ is defined by $1_{k}(\overrightarrow{x}) = 1$ inside cell *k* and $1_{k}(\overrightarrow{x}) = 0$ otherwise. All products of vectors are element-wise.

While most multicellular models \[e.g. Morpheus ([@btv730-B5]), Chaste ([@btv730-B4])\] include diffusion solvers, they generally are not designed to scale well to large 3D domains with more than a few substrates. Most are not designed for multithreaded parallelization on multicore desktops. The solvers tend to use explicit time steppings (require strict stability restrictions on $\Delta t$) or implicit time steppings (stable but require inverting large matrix systems). Those that invert large linear systems often have large dependencies that complicate cross-platform use.

BioFVM implements simple methods that can readily be parallelized by OpenMP. It can efficiently and accurately simulate systems of 5--10 or more diffusing substrates on 1--10 million or more voxels, with desktop workstations or single compute nodes. The code is first-order accurate in time and second-order accurate in space. Its performance scales linearly in the number of substrates (it takes 2.6× longer to increase from 1 to 10 substrates), the number of voxels and the number of cells. The code is stable; it often achieves good accuracy with $\Delta t = 0.01$ to 0.1 min.

2 Method and implementation
===========================

We use a first-order, implicit (and stable) operator splitting, allowing us to create separate, optimized solvers for the diffusion-decay, cell-based source/sinks and bulk source/sinks ([@btv730-B3]). We solve the diffusion-decay terms using the finite volume method ([@btv730-B1]), further accelerated by an additional first-order splitting into separate solutions in the *x*-, *y*- and *z*-directions via the locally one-dimensional method (LOD) ([@btv730-B3]; [@btv730-B7]). For each dimension, we solve the resulting tridiagonal linear systems with the Thomas algorithm ([@btv730-B6]). We use OpenMP where loops can be parallelized (e.g. many instances of the Thomas solver when solving *x*-diffusion across multiple strips of domain). Other optimizations include storing pre-computations and overloading vector operations. The C ++ implementation is described in further detail in the [supplementary materials](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv730/-/DC1).

3 Examples
==========

3.1 Oxygen and VEGF diffusion in a large tissue
-----------------------------------------------

In [Figure 1](#btv730-F1){ref-type="fig"}, we simulated 1 hour of diffusive transport in 125 mm^3^ of vascularized tissue (red curves, panel A) with a large irregular tumor (green cells, panel A) at 20 μm resolution (15 625 000 voxels) and $\Delta t = 0.01$ min. Oxygen is released by the vessels (a series of cell-centered sources), diffuses through the tissue and is consumed by tumor cells. For technical illustration, tumor cells release VEGF where $\text{pO}_{2} < 15$ mmHg, which diffuses through the domain. Further biology, parameter values and references are discussed in the [supplementary materials](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv730/-/DC1). In panel A, the vasculature is rendered up to the gray clipping plane for clearer illustration. Panel B shows the tumor cells and vessels in the gray clipping plane. Panels C--D shows the concentration of oxygen and VEGF in this plane. The red contour marks the tumor boundary. This simulation---with 2.8 million cell source/sink terms---required $\sim 80$ minutes on a quad-core desktop computer (Intel i7 4790, 3.60 GHz, 16 GB of memory); similar problems on 1 million voxels require 5--10 min. Fig. 1Simulation of oxygen and VEGF diffusion in a highly vascularized tissue with a multifocal tumor lesion; vasculature is rendered up to the gray clipping plane (**A**). Vessels and tumor cells in the gray clipping plane (**B**). Oxygen distribution in (**C**) shows significant hypoxia (blue areas, pO2 \< 15 mmHg) within the tumor (red outline). Hypoxic tumor cells release VEGF to stimulate further vascularization (**D**) (Color version of this figure is available at *Bioinformatics* online.)

3.2 Convergence testing
-----------------------

Tests for several 1D and 3D problems showed first-order accuracy in time, second-order accuracy in space and stability even for large time steps. Using $\Delta t = 0.01$ min gave reasonable accuracy for most problems. The convergence tests are fully detailed in the [supplementary materials](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv730/-/DC1).

3.3 Performance testing
-----------------------

We tested diffusion of $N = 1$ to 128 substrates with $D \sim 10^{5}\mu\text{m}^{2}/\text{min}$ (typical magnitude for cancer biology) in a 1 mm^3^ domain at 10 $\mu\text{m}$ resolution (1 million voxels) with $\Delta t = 0.01$ min. Computational cost (wall time for 4 min of diffusion) scaled linearly with *N*; increasing from 1 to 10 substrates increased computational cost by $\sim 2.6 \times$. In other tests, computational cost scaled linearly with the number of voxels (domain size) and the number of cells. Full results are in the [supplementary materials](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv730/-/DC1).

4 Obtaining software and licensing
==================================

BioFVM is available from [BioFVM.MathCancer.org](http://BioFVM.MathCancer.org) and [BioFVM.sf.net](http://BioFVM.sf.net) under the Apache License (v2.0). A tutorial on using the code is included with the BioFVM download, along with several examples.

5 Discussion
============

BioFVM can efficiently and accurately simulate several diffusing substrates in large 3D domains, with both bulk and cell-based source and uptake terms. While it can run on its own (with minimal software dependencies), it is well-suited for inclusion in larger modeling packages. Beyond simulating the transport of drugs and growth substrates, BioFVM's ability to simulate dozens of compounds should make 3D simulations of multicellular secretomics and multiscale cell responses feasible. In future releases, we plan to add upwinded advective solvers, more adaptive time stepping for cell-based source/sink terms and support for general Voronoi meshes.
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